Maryland 70.3 Half Ironman
After quietly taking part in Haines City, Fl. 70.3 Ironman earlier this year, I have decided to tackle another. This time round, it will be closer to home. I am taking part in the Eagleman 70.3 Ironman in Cambridge, MD on the 9th June 2019.
I am going to help a great cause, and together we can make a difference in the fight against Crohn’s disease and ulcerative colitis. This will be a big undertaking, but it will all be worth it because your donations will not only motivate me to the finish, but they will help us get closer to the cure. Please consider a donation today.
What is Crohn’s disease and ulcerative colitis?
Known collectively as inflammatory bowel diseases (IBD), Crohn’s disease and ulcerative colitis affects almost 1 in 100 people. They are painful, medically incurable diseases that attack the digestive system. Crohn's disease may attack anywhere along the digestive tract, while ulcerative colitis inflames only the large intestine (colon). Symptoms may include abdominal pain, persistent diarrhea, rectal bleeding, fever, and weight loss. Many patients require numerous hospitalizations and surgery. Most people develop the diseases between the ages of 15 and 35; however the incidence is increasing in children.
The Crohn's & Colitis Foundation is the largest non-profit, voluntary, health organization dedicated to finding cures for inflammatory bowel diseases (IBD). The Foundation’s mission is to cure Crohn's disease and ulcerative colitis, and to improve the quality of life of children and adults who are affected by these diseases. The Foundation works to fulfill its mission by funding research; providing educational resources for patients and their families, medical professionals, and the public; and furnishing supportive services for those afflicted with IBD.
Has made a donation to this event
Fundraising Honor Roll
Brian & Alison Nicholson
Brian & Sara Murphy
Henrik & Sharon
Jen & Ad
Kim and Jay
Last Frontier Farm
Mr. Tim and Ellie Dorr
Ms. Lauren Kieffer
Trev & Gill
If you think this page contains objectionable content, please inform the system administrator.